ChrysCapital acquires Novartis India

ChrysCapital agreed to acquire Novartis India. Reported deal value: Undisclosed. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.

This page summarizes publicly available information about the transaction as of 2026-02-19. Figures and status may change as filings and press coverage update.

MC EXCLUSIVE ChrysCapital in final stage talks to acquire parent Novartis AG stake in Novartis India If the deal goes through, it would mark the first majority deal for Chrys Capital in the India n pharma segment, sources told Moneycontrol Ashwin Mohan February 19, 2026 / 23:47 IST Novartis AG holds a 70.68 per cent stake in its listed India n arm which had a market cap of Rs 2,050.45 crore ChrysCapital nears deal to acquire Novartis AG stake in Novartis India Deal could prompt open offer, boost ChrysCapital pharma footprint Novartis AG holds 70.68% of Novartis India , worth Rs 1,450 crore ...